Tickers

1. Composite Trajectory Verdict

Given MKTW's subscription model where Billings are invoiced upfront but revenue is recognized ratably over up to five years, all three statements carry roughly equal weight: the income statement reflects recognized revenue from past Billings, the cash flow statement captures current Billings momentum and operating cash generation, and the balance sheet shows the deferred revenue liability and liquidity position that bridge the two.

Composite Trajectory: Mixed

The annual GAAP revenue trend is deteriorating, falling 19.7% to $328.1 million in 2025 from $408.7 million in 2024 after an 8.8% decline in 2024 (10-K 2025-12-31, Consolidated Statements of Operations). Net income dropped to $64.0 million in 2025 from $93.1 million in 2024, though it remains above the $54.3 million in 2023 (10-K 2025-12-31, Consolidated Statements of Operations). Conversely, quarterly cash generation is improving: Q2 2026 CFFO rose 25.7% year-over-year to $22.4 million (10-Q 2026-06-30, MD&A) and six-month CFFO increased 3.9% to $20.3 million (10-Q 2026-06-30, Cash Flows). Billings surged 56.7% in Q2 2026 to $91.2 million and 34.1% for the first half to $172.5 million (10-Q 2026-06-30, Key Business Metrics), while paid subscribers stabilized near 400 thousand (10-Q 2026-06-30, Key Business Metrics). The balance sheet shows declining liquidity, with cash falling to $32.9 million at June 30, 2026 from $70.1 million at December 31, 2025 (10-Q 2026-06-30, Liquidity and Capital Resources; 10-K 2025-12-31, Consolidated Balance Sheets), and a persistent stockholders' deficit of $(213.6) million at year-end 2025 (10-K 2025-12-31, Consolidated Balance Sheets).

2. Red Flags

• GAAP revenue declining while Billings surge: Q2 2026 total net revenue fell 5.2% year-over-year to $75.8 million while Billings jumped 56.7% to $91.2 million (10-Q 2026-06-30, Results of Operations; Key Business Metrics), widening the perpetual disconnect noted by management.
• Net loss despite positive operating cash flow: Q2 2026 reported a net loss of $(2.6) million but generated $22.4 million CFFO (10-Q 2026-06-30, Results of Operations; Cash Flows), driven by deferred revenue and contract cost timing.
• Cash balance declining sharply: Cash and equivalents dropped from $70.1 million at December 31, 2025 (10-K 2025-12-31, Consolidated Balance Sheets) to $32.9 million at June 30, 2026 (10-Q 2026-06-30, Liquidity and Capital Resources), a 53% decline in six months.
• Persistent stockholders' deficit: Total stockholders' deficit was $(213.6) million at December 31, 2025 (10-K 2025-12-31, Consolidated Balance Sheets), with liabilities exceeding assets.
• Tax Receivable Agreement liability growing: TRA liability increased to $4.3 million at December 31, 2025 from $2.7 million at December 31, 2024 (10-K 2025-12-31, Consolidated Balance Sheets), with potential for significant future payments.
• Impairment charges recurring: Impairment losses of $0.4 million in 2025, $4.4 million in 2024, and $2.6 million in 2023 (10-K 2025-12-31, Consolidated Statements of Operations) related to Legacy Research and Buttonwood Publishing disposals.
• Paid subscriber base down 49% over two years: Paid subscribers fell from 737,140 at December 31, 2023 to 374,163 at December 31, 2025 (10-K 2025-12-31, Key Business Metrics), though they ticked up to 399,866 at June 30, 2026 (10-Q 2026-06-30, Key Business Metrics).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Annual GAAP revenue has declined for three consecutive years: $448.2 million in 2023, $408.7 million in 2024 (-8.8%), and $328.1 million in 2025 (-19.7%) (10-K 2025-12-31, Consolidated Statements of Operations). Net income peaked at $93.1 million in 2024 before falling to $64.0 million in 2025, though still above the $54.3 million in 2023 (10-K 2025-12-31, Consolidated Statements of Operations). Operating income followed a similar pattern: $51.8 million (2023), $89.0 million (2024), $62.6 million (2025) (10-K 2025-12-31, Consolidated Statements of Operations). Quarterly results show accelerating deterioration: Q2 2026 posted a net loss of $(2.6) million versus net income of $15.3 million in Q2 2025 (10-Q 2026-06-30, Results of Operations), and a six-month net loss of $(3.2) million versus $32.2 million income in the prior-year period (10-Q 2026-06-30, Results of Operations). Total operating expenses as a percentage of net revenue rose to 105.6% in Q2 2026 from 81.5% in Q2 2025 (10-Q 2026-06-30, Results of Operations), driven by a 35.4% increase in sales and marketing expense to $42.8 million (10-Q 2026-06-30, Operating Expenses).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Annual CFFO swung from $62.4 million in 2023 to $(22.2) million in 2024, then recovered to $46.0 million in 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). Free Cash Flow followed the same pattern: $60.7 million, $(22.8) million, $44.4 million (10-K 2025-12-31, Non-GAAP Financial Measures). Quarterly trends show consistent year-over-year improvement: Q2 2026 CFFO increased 25.7% to $22.4 million from $17.8 million in Q2 2025 (10-Q 2026-06-30, Non-GAAP Financial Measures), and six-month CFFO rose 3.9% to $20.3 million from $19.6 million (10-Q 2026-06-30, Non-GAAP Financial Measures). Free Cash Flow similarly improved: Q2 2026 FCF of $21.4 million versus $17.5 million in Q2 2025 (+22.3%) (10-Q 2026-06-30, Non-GAAP Financial Measures). The improvement coincides with Billings growth of 56.7% in Q2 2026 and 34.1% for the first half (10-Q 2026-06-30, Key Business Metrics), though capital expenditures also rose to $1.0 million in Q2 2026 from $0.3 million in Q2 2025 (10-Q 2026-06-30, Free Cash Flow).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets declined from $259.5 million at December 31, 2024 to $218.4 million at December 31, 2025 (10-K 2025-12-31, Consolidated Balance Sheets), driven by a $27.7 million drop in cash to $70.1 million and a $13.8 million reduction in deferred contract acquisition costs to $78.1 million (current + noncurrent) (10-K 2025-12-31, Consolidated Balance Sheets; Note 3). Total liabilities fell from $477.4 million to $432.0 million over the same period, primarily due to a $39.2 million decrease in current deferred revenue and a $23.3 million decrease in noncurrent deferred revenue (10-K 2025-12-31, Consolidated Balance Sheets). The stockholders' deficit narrowed slightly from $(217.9) million to $(213.6) million (10-K 2025-12-31, Consolidated Balance Sheets). In the first half of 2026, cash fell further to $32.9 million at June 30, 2026 (10-Q 2026-06-30, Liquidity and Capital Resources), a 53% decline from year-end 2025, while the company paid $49.8 million in tax distributions to noncontrolling interests and $4.8 million in dividends during 2025 (10-K 2025-12-31, Consolidated Statements of Cash Flows). The TRA liability grew to $4.3 million at December 31, 2025 (10-K 2025-12-31, Consolidated Balance Sheets) and stood at $3.1 million at June 30, 2026 (10-Q 2026-06-30, Liquidity and Capital Resources).

6. Data Gaps

• Quarterly income statement, cash flow, and balance sheet data for Q3 2025, Q4 2025, and Q1 2025 (only Q2 2025 and Q2 2026 are directly comparable in the 10-Q 2026-06-30 filing)
• Full quarterly breakdown of 2025 results (10-K provides only annual figures)
• Quarterly deferred revenue and deferred contract acquisition cost balances for 2026 periods (only annual figures in 10-K Note 3)
• Quarterly TRA liability movements for 2025 and 2026 (only annual and June 30, 2026 snapshots provided)
• Segment-level GAAP financials for quarterly periods (10-K Note 16 provides only annual Adjusted Basis segment data)